PNOPX
Price
$120.61
Change
+$0.44 (+0.37%)
Updated
Jun 12 closing price
Net Assets
6.2B
VIGIX
Price
$215.36
Change
-$2.91 (-1.33%)
Updated
Jun 13 closing price
Net Assets
293.94B
Interact to see
Advertisement

PNOPX vs VIGIX

Header iconPNOPX vs VIGIX Comparison
Open Charts PNOPX vs VIGIXBanner chart's image
Putnam Sustainable Leaders A
Price$120.61
Change+$0.44 (+0.37%)
VolumeN/A
Net Assets6.2B
Vanguard Growth Index Institutional
Price$215.36
Change-$2.91 (-1.33%)
VolumeN/A
Net Assets293.94B
PNOPX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PNOPX vs. VIGIX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PNOPX is a Buy and VIGIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 294B vs. PNOPX (6.2B). PNOPX (0.49) and VIGIX (0.47) have matching dividends . PNOPX was incepted earlier than VIGIX: PNOPX (35 years) vs VIGIX (27 years). PNOPX (0.87) is less costly to investors than VIGIX (0.04). PNOPX is a more actively managed with annual turnover of: 22.00 vs. VIGIX (11.00). PNOPX has a lower initial minimum investment than VIGIX: PNOPX (0) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 14.12 vs. PNOPX (-6.63). VIGIX return over 5 years is better than : 117.71 vs. PNOPX (28.89).
PNOPXVIGIXPNOPX / VIGIX
Total Expense Ratio0.870.042,175%
Annual Report Gross Expense Ratio0.870.042,175%
Fund Existence35 years27 years-
Gain YTD-1.8463.134-59%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets6.2B294B2%
Annual Yield % from dividends0.490.47104%
Returns for 1 year-6.6314.12-47%
Returns for 3 years32.9093.9135%
Returns for 5 years28.89117.7125%
Returns for 10 years54.78293.1719%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APDN5.070.42
+9.05%
Applied DNA Sciences Inc
GEN30.270.83
+2.82%
Gen Digital
MCY65.210.53
+0.82%
Mercury General Corp
IMOS19.80-0.25
-1.25%
ChipMOS TECHNOLOGIES
FATE1.40-0.15
-9.68%
Fate Therapeutics